The Wolverine stack
BPC-157 and TB-500 for injury recovery.
A linked source is not a clinical endorsement. How we handle review and corrections.
What's in it
Why people combine them
BPC-157 is thought to work on blood vessel growth and the gut lining. TB-500 is thought to help cells move into injured tissue. The theory is that they cover different steps of repair.
The honest part
Nobody has tested the pair together in a human trial, and neither half has a published randomized trial on its own. The name comes from a comic-book character who heals fast. It's marketing, not medicine.
How Goodmorrow does it
- Two separate vials, dosed separately, so your clinician can adjust one without the other.
- A set start and end date, with a check-in to decide whether it helped.
- A licensed 503A pharmacy only. No research-grade vials.
What you can do today
If you're injured now, start with a diagnosis. Your clinician will tell you what's worth doing today and refer you when an injury needs imaging or a specialist.
Questions people ask
Is the Wolverine stack legal?
Not yet. Both peptides were recommended for compounding in July 2026, but pharmacies can't make them until the FDA finalizes that decision.
Can athletes use it?
Not in tested sport. Both BPC-157 and TB-500 are prohibited under the World Anti-Doping Code.
Sources
- FDA documentJuly 23-24, 2026 Meeting of the Pharmacy Compounding Advisory Committee U.S. Food and Drug Administration, July 2026
- Secondary sourceFDA Panel Votes to Loosen Restrictions for Four Peptides PharmExec, July 2026
- Secondary sourceFDA advisory committee nominates six peptides for pharmacies to compound National Community Pharmacists Association, July 31, 2026
- Secondary sourceBPC-157: Experimental Peptide Creates Risk for Athletes USADA
- Secondary sourceTB-500: Status, Risks, and Bans in Sport and Military BSCG
Good days ahead.
Join the opening list for appointment updates.